Skip to main content
Premium Trial:

Request an Annual Quote

Ultima Genomics: Mirna Jarosz and Shlomey Derhi

Ultima Genomics has appointed Mirna Jarosz as head of product strategy. Prior to joining Ultima, Jarosz served as general manager for the NGS business at Integrated DNA Technologies (IDT). Jarosz earned a PhD in physical chemistry from the Massachusetts Institute of Technology and a BS in chemistry from the University of Washington. The firm also appointed Shlomey Derhi as head of architecture and integration. Derhi has an MS in systems engineering and a BS in electrical and electronics engineering from Tel Aviv University.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.